These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 35242773

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Patient classification and outcome prediction in IgA nephropathy.
    Diciolla M, Binetti G, Di Noia T, Pesce F, Schena FP, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Naso D.
    Comput Biol Med; 2015 Nov 01; 66():278-86. PubMed ID: 26453758
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The Density of Renal Lymphatics Correlates With Clinical Outcomes in IgA Nephropathy.
    Rodas L, Barnadas E, Pereira A, Castrejon N, Saurina A, Calls J, Calzada Y, Madrid Á, Blasco M, Poch E, García-Herrera A, Quintana LF, Catalán Group for the Study of Glomerular Diseases (GLOMCAT).
    Kidney Int Rep; 2022 Apr 01; 7(4):823-830. PubMed ID: 35497787
    [Abstract] [Full Text] [Related]

  • 26. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L, Cai K, Wang K, Luo Q.
    J Clin Lab Anal; 2021 Jun 01; 35(6):e23774. PubMed ID: 33951240
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R.
    Am J Nephrol; 2015 Jun 01; 41(3):210-9. PubMed ID: 25872002
    [Abstract] [Full Text] [Related]

  • 32. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool.
    Barbour SJ, Canney M, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Induruwage D, Er L, Reich HN, Feehally J, Barratt J, Cattran DC, International IgA Nephropathy Network.
    Kidney Int; 2020 Oct 01; 98(4):1009-1019. PubMed ID: 32464215
    [Abstract] [Full Text] [Related]

  • 33. Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy.
    Hwang D, Choi K, Cho NJ, Park S, Yu BC, Gil HW, Lee EY, Choi SJ, Park MY, Kim JK, Hwang SD, Kwon SH, Jeon JS, Noh H, Han DC, Kim H.
    Nephrology (Carlton); 2021 Jul 01; 26(7):594-602. PubMed ID: 33624915
    [Abstract] [Full Text] [Related]

  • 34. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X, Lv J, Wang Z, Ren H, Shen P, Wang W, Zhang H, Xie J, Chen N.
    J Transl Med; 2018 May 03; 16(1):115. PubMed ID: 29724226
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S, Li JP.
    Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076
    [Abstract] [Full Text] [Related]

  • 38. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z, Tan J, Wang S, Dong L, Han X, Tang Y, Qin W.
    Int J Med Sci; 2021 Jan 06; 18(13):2964-2970. PubMed ID: 34220324
    [Abstract] [Full Text] [Related]

  • 39. Blood and urine biomarkers of disease progression in IgA nephropathy.
    Duan ZY, Zhang C, Chen XM, Cai GY.
    Biomark Res; 2024 Jul 29; 12(1):72. PubMed ID: 39075557
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.